Kristine M. Jacques - 08 May 2024 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Role
Director
Signature
/s/ Kristine M. Jacques
Issuer symbol
TNON
Transactions as of
08 May 2024
Net transactions value
$0
Form type
4
Filing time
22 Dec 2025, 12:40:58 UTC
Previous filing
29 Mar 2024
Next filing
15 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jacques Kristine M Director 104 COOPER COURT, LOS GATOS /s/ Kristine M. Jacques 22 Dec 2025 0002017818

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNON Restricted Stock Units Award $0 +1,750 $0.000000 1,750 08 May 2024 Common Stock 1,750 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of 1,750 (as adjusted for 1-for-8 reverse stock split effected by the Issuer on September 6, 2024) restricted stock units ("RSUs") of the Issuer pursuant to Tenon Medical, Inc. 2022 Equity Incentive Plan, as amended. Each RSU will vest and automatically convert into shares of common stock of the Issuer (on one-for-one basis) as follows: 583 RSUs on January 1, 2026; 583 RSUs on May 8, 2026, and 584 RSUs on May 8, 2027.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
F3 N/A